• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌恢复后取出INCOR左心室辅助装置

Explantation of INCOR left ventricular assist device after myocardial recovery.

作者信息

Komoda Takeshi, Komoda Satsuki, Dandel Michael, Weng Yuguo, Hetzer Roland

机构信息

Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum, Berlin, Germany.

出版信息

J Card Surg. 2008 Nov-Dec;23(6):642-7. doi: 10.1111/j.1540-8191.2008.00665.x.

DOI:10.1111/j.1540-8191.2008.00665.x
PMID:19016989
Abstract

OBJECTIVES

Myocardial recovery in patients supported by the INCOR left ventricular assist device (LVAD; Berlin Heart GmbH, Berlin, Germany) is seen in 5% of patients on this device worldwide. We describe improved surgical techniques for INCOR LVAD explantation.

METHODS

The outcome of INCOR LVAD implantation at our center and the operative techniques of device explantation were studied. The patients weaned from the device were followed up.

RESULTS

Out of 121 patients supported by the device, five (4.1 %) were weaned from the device, whereas 34 patients (28.1 %) underwent heart transplantation. In explantation surgery, the inflow cannula was removed (one case) or remained in the left ventricle after occlusion with an inflow cannula plug, with transection of the inflow cannula at its curve (two cases) or without transection (two cases). When the inflow cannula was occluded without the support of cardiopulmonary bypass (two cases), operative time (180 min and 210 min) was shorter than that with other explantation procedures. After mean follow-up of 2.4 years (range two months-four years) after device explantation, all five patients are alive, have not required heart transplantation and are in New York Heart Association class I (one case) or class II (four cases). After weaning from the device, no cerebrovascular complication was observed in any of the five patients.

CONCLUSIONS

There is a possibility of weaning after INCOR implantation and surgical techniques for the removal of the INCOR LVAD should be further developed.

摘要

目的

在全球范围内,接受INCOR左心室辅助装置(LVAD;德国柏林柏林心脏有限公司)支持的患者中,有5%出现心肌恢复。我们描述了改进的INCOR LVAD植入手术技术。

方法

研究了我们中心INCOR LVAD植入的结果以及装置移除的手术技术。对脱离该装置的患者进行了随访。

结果

在121例接受该装置支持的患者中,5例(4.1%)脱离了该装置,而34例患者(28.1%)接受了心脏移植。在植入物移除手术中,流入插管被移除(1例),或在使用流入插管封堵器封堵后留在左心室,流入插管在其弯曲处被切断(2例)或未被切断(2例)。当在没有体外循环支持的情况下封堵流入插管时(2例),手术时间(180分钟和210分钟)比其他植入物移除手术短。在装置移除后平均随访2.4年(范围为2个月至4年),所有5例患者均存活,无需进行心脏移植,纽约心脏协会心功能分级为I级(1例)或II级(4例)。在脱离该装置后,5例患者中无一例出现脑血管并发症。

结论

INCOR植入后有可能脱离装置,应进一步开发移除INCOR LVAD的手术技术。

相似文献

1
Explantation of INCOR left ventricular assist device after myocardial recovery.心肌恢复后取出INCOR左心室辅助装置
J Card Surg. 2008 Nov-Dec;23(6):642-7. doi: 10.1111/j.1540-8191.2008.00665.x.
2
First clinical experience with the Incor left ventricular assist device.Incor左心室辅助装置的首次临床经验。
J Heart Lung Transplant. 2005 Sep;24(9):1188-94. doi: 10.1016/j.healun.2004.08.024.
3
Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.终末期扩张型心肌病心脏恢复后接受左心室辅助装置移除术患者的中期随访。
J Thorac Cardiovasc Surg. 2000 Nov;120(5):843-53. doi: 10.1067/mtc.2000.108931.
4
Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.与左心室辅助装置功能障碍相关的复发性心力衰竭评估
J Heart Lung Transplant. 2005 Dec;24(12):2060-7. doi: 10.1016/j.healun.2005.05.016. Epub 2005 Oct 14.
5
Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?在特发性扩张型心肌病患者接受长期左心室机械支持期间,谁会是恢复过渡治疗的合适人选?
J Thorac Cardiovasc Surg. 2005 Sep;130(3):699-704. doi: 10.1016/j.jtcvs.2005.05.016.
6
Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.联合左心室辅助装置和克伦特罗治疗后心力衰竭恢复期间心肌胰岛素样生长因子-I基因表达
Circulation. 2005 Aug 30;112(9 Suppl):I46-50. doi: 10.1161/01.CIRCULATIONAHA.105.525873.
7
Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.接受连续流左心室辅助装置支持的患者的心室重塑与泵移除术
J Heart Lung Transplant. 2015 Jun;34(6):766-72. doi: 10.1016/j.healun.2014.09.015. Epub 2014 Sep 28.
8
Clinical situations demanding weaning from long-term ventricular assist devices.需要从长期心室辅助装置撤机的临床情况。
Eur J Cardiothorac Surg. 2004 Oct;26(4):730-5. doi: 10.1016/j.ejcts.2004.07.020.
9
Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy.扩张型心肌病患者应用左心室辅助装置前后心肌胶原含量的变化
Chin Med J (Engl). 2004 Mar;117(3):401-7.
10
Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure.搏动性和非搏动性左心室辅助装置对终末期心力衰竭患者肾素-血管紧张素系统的影响。
Thorac Cardiovasc Surg. 2010 Feb;58 Suppl 2:S185-8. doi: 10.1055/s-0029-1240709. Epub 2010 Jan 25.

引用本文的文献

1
Role of Echocardiography in the Management of Patients with Advanced (Stage D) Heart Failure Related to Nonischemic Cardiomyopathy.超声心动图在晚期(D期)非缺血性心肌病相关心力衰竭患者管理中的作用
Rev Cardiovasc Med. 2022 Jun 15;23(6):214. doi: 10.31083/j.rcm2306214. eCollection 2022 Jun.
2
Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure.左心室结构和功能重构的时间模式,在逆转容量超负荷性心力衰竭后。
J Appl Physiol (1985). 2011 Dec;111(6):1778-88. doi: 10.1152/japplphysiol.00691.2011. Epub 2011 Sep 1.